{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-24-000007","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.137222+00:00","generated_at":"2026-06-06T05:08:17.243511+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"medium","headline":"ANI Pharmaceuticals to present at Guggenheim Healthcare Talks Biotechnology Conference","bullets":["CEO Nikhil Lalwani and senior leadership to present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Feb 8, 2024.","Investor presentation dated February 2024 attached as Exhibit 99.1.","Disclosure made under Items 2.02 and 7.01 of Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-24-000007","json":"https://secwatch.observer/filing/0001023024-24-000007.json","markdown":"https://secwatch.observer/filing/0001023024-24-000007.md","text":"https://secwatch.observer/filing/0001023024-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/0001023024-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/ani-20240208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T05:08:17.243511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}